MygoGenesis™ Is Unleashing the Power of Cellular Medicine.  
The Mygotic™ proprietary process turns somatic cells to totipotent cells and then to any cell or tissue. 


It is revolutionizing Cell Therapy, Gene Therapy, and Regenerative medicine. It is a Pipeline within a Process.

The Initial Focus of MygoGenesis™ is on Four Product Pathways to Commercialization with More in the Pipeline:

1. AmeboGenesis™- Laboratory Amebocyte Production for Producers of LAL, the Gold Standard for Pharma and Medical Device Safety Testing for Bacterial Endotoxins.

2. HematoGenesis™- Limitless Production of Human Blood Focusing on Type O Negative Blood and Platelets

3. MyCellSafe™-Be Your Best Donor for Autologous Totipotent Cells, Always Available for Every Patient and Every Treatment and Regenerative Medicine

4. The Production of a Broad Range of Cells for Research- In Partnership with or for Licensing to Life Science Leaders in Cell Therapeutics, Gene Therapies, and Regenerative Medicine.

MygoGenesis

Org chart

Teams

Offices